SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways
2016 ◽
Vol 7
(5)
◽
pp. e2216-e2216
◽